These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 9070496

  • 1. Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity.
    Mizutani Y, Okada Y, Yoshida O, Fukumoto M, Bonavida B.
    Cancer; 1997 Mar 15; 79(6):1180-9. PubMed ID: 9070496
    [Abstract] [Full Text] [Related]

  • 2. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 15; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 3. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
    Mizutani Y, Yoshida O, Miki T, Bonavida B.
    Clin Cancer Res; 1999 Sep 15; 5(9):2605-12. PubMed ID: 10499639
    [Abstract] [Full Text] [Related]

  • 4. Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil.
    Mizutani Y, Wu XX, Yoshida O, Shirasaka T, Bonavida B.
    Oncol Rep; 1999 Sep 15; 6(5):979-82. PubMed ID: 10425290
    [Abstract] [Full Text] [Related]

  • 5. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y, Nakao M, Ogawa O, Yoshida O, Bonavida B, Miki T.
    J Urol; 2001 Jan 15; 165(1):263-70. PubMed ID: 11125422
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
    Mizutani Y, Fukumoto M, Bonavida B, Yoshida O.
    Cancer; 1994 Nov 01; 74(9):2546-54. PubMed ID: 7923012
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R, Borsellino N, Frost P, Gárban H, Ng CP, Mizutani Y, Belldegrun A, Bonavida B.
    Clin Cancer Res; 1997 Jun 01; 3(6):963-72. PubMed ID: 9815772
    [Abstract] [Full Text] [Related]

  • 10. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.
    Mizutani Y, Kamoi K, Ukimura O, Kawauchi A, Miki T.
    J Urol; 2002 Dec 01; 168(6):2650-4. PubMed ID: 12442003
    [Abstract] [Full Text] [Related]

  • 11. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis.
    Uslu R, Jewett A, Bonavida B.
    Gynecol Oncol; 1996 Aug 01; 62(2):282-91. PubMed ID: 8751562
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin.
    Jin X, Wu XX, Abdel-Muneem Nouh MA, Kakehi Y.
    J Urol; 2007 May 01; 177(5):1894-9. PubMed ID: 17437844
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system.
    McGahon AJ, Costa Pereira AP, Daly L, Cotter TG.
    Br J Haematol; 1998 Jun 01; 101(3):539-47. PubMed ID: 9633899
    [Abstract] [Full Text] [Related]

  • 15. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
    Morimoto H, Yonehara S, Bonavida B.
    Cancer Res; 1993 Jun 01; 53(11):2591-6. PubMed ID: 7684321
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.
    Mizutani Y, Nakanishi H, Yoshida O, Fukushima M, Bonavida B, Miki T.
    Eur J Cancer; 2002 Jan 01; 38(1):167-76. PubMed ID: 11750847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells.
    Ahmed SM, Wu X, Jin X, Zhang X, Togo Y, Suzuki T, Li Y, Kanematsu A, Nojima M, Yamamoto S, Sugimoto M, Kakehi Y.
    Oncol Rep; 2015 Feb 01; 33(2):566-72. PubMed ID: 25483927
    [Abstract] [Full Text] [Related]

  • 19. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Wu XX, Zeng Y, Jin XH, Kakehi Y.
    Oncol Rep; 2007 Aug 01; 18(2):353-9. PubMed ID: 17611656
    [Abstract] [Full Text] [Related]

  • 20. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
    Mizutani Y, Nakanishi H, Li YN, Sato N, Kawauchi A, Miki T.
    J Urol; 2004 Oct 01; 172(4 Pt 1):1474-9. PubMed ID: 15371874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.